These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20376628)

  • 21. Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole.
    Ormeci A; Emrence Z; Baran B; Gokturk S; Soyer OM; Evirgen S; Akyuz F; Karaca C; Besisik F; Kaymakoglu S; Ustek D; Demir K
    Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):879-85. PubMed ID: 27010145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype.
    Lee SB; Park SJ; Ryu JK; Lee JK; Kim HJ; Bae JS; Jung HS; Park SM
    Korean J Gastroenterol; 2003 Dec; 42(6):468-75. PubMed ID: 14695703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvements in Helicobacter pylori eradication rates through clinical CYP2C19 genotyping.
    Tamura T; Kurata M; Inoue S; Kondo T; Goto Y; Kamiya Y; Kawai S; Hamajima N
    Nagoya J Med Sci; 2011 Feb; 73(1-2):25-31. PubMed ID: 21614934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics.
    Adamek RJ; Pfaffenbach B; Szymanski C
    Helicobacter; 1998 Sep; 3(3):206-11. PubMed ID: 9731993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis.
    Shah SC; Tepler A; Chung CP; Suarez G; Peek RM; Hung A; Roumie C; Narula N
    Gastroenterology; 2021 Nov; 161(5):1443-1459. PubMed ID: 34358488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy.
    Prasertpetmanee S; Mahachai V; Vilaichone RK
    Helicobacter; 2013 Aug; 18(4):270-3. PubMed ID: 23356886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
    Yang JC; Wang HL; Chern HD; Shun CT; Lin BR; Lin CJ; Wang TH
    Pharmacotherapy; 2011 Mar; 31(3):227-38. PubMed ID: 21361732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
    Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
    Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients.
    Sun WH; Ou XL; Cao DZ; Yu Q; Yu T; Hu JM; Zhu F; Sun YL; Fu XL; Su H
    World J Gastroenterol; 2005 Apr; 11(16):2477-81. PubMed ID: 15832421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.
    Lee JY; Kim N; Kim MS; Choi YJ; Lee JW; Yoon H; Shin CM; Park YS; Lee DH; Jung HC
    Dig Dis Sci; 2014 Jun; 59(6):1235-43. PubMed ID: 24599773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection.
    Hsu PI; Kao SS; Wu DC; Chen WC; Peng NJ; Yu HC; Wang HM; Lai KH; Cheng JS; Chen A; Chuah SK; Tsay FW;
    Medicine (Baltimore); 2015 Dec; 94(48):e2104. PubMed ID: 26632893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia.
    Chan CC; Chien NH; Lee CL; Yang YC; Hung CS; Tu TC; Wu CH
    BMC Gastroenterol; 2015 Dec; 15():170. PubMed ID: 26635102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Short-term triple therapy with pantoprazole, amoxicillin and metronidazole in Helicobacter pylori infection].
    Glaser J; Hein J; Daikeler R; Weithofer G; Vieth M; Schmidt M; Stolte M
    Med Klin (Munich); 1998 Feb; 93(2):65-9. PubMed ID: 9545703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified sequential Helicobacter pylori eradication therapy using high dose omeprazole and amoxicillin in the initial phase in the extensive metaboliser Turkish patients for CYP2C19 polymorphism is ineffective.
    Sezgin O; Barlas IO; Uçbilek E; Yengel E; Altintaş E
    Acta Gastroenterol Belg; 2014 Mar; 77(1):3-7. PubMed ID: 24761684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
    Boixeda D; Bermejo F; Martín-De-Argila C; López-Sanromán A; Defarges V; Hernández-Ranz F; Milicua JM; García-Plaza A
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1457-60. PubMed ID: 12182745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of smoking and CYP2C19 genotypes on H. pylori eradication success.
    Suzuki T; Matsuo K; Sawaki A; Wakai K; Hirose K; Ito H; Saito T; Nakamura T; Yamao K; Hamajima N; Tajima K
    Epidemiol Infect; 2007 Jan; 135(1):171-6. PubMed ID: 16740190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori.
    Sugimoto M; Furuta T; Yamaoka Y
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1725-32. PubMed ID: 20136959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the efficacy of the two tetracycline-containing sequential therapy regimens for the eradication of Helicobacter pylori: 5 days versus 14 days amoxicillin.
    Cetinkaya ZA; Sezikli M; Güzelbulut F; Coşgun S; Düzgün S; Kurdaş OO
    Helicobacter; 2010 Apr; 15(2):143-7. PubMed ID: 20402816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.